한글목차

유방암 검진 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 24억 9,000만 달러에서 2026년에는 26억 9,000만 달러로, CAGR 8.3%로 확대가 전망되고 있습니다. 지난 수년간의 성장에는 유방암 발병률에 대한 의식의 향상, 유방촬영술 검진 프로그램의 광범위한 도입, 진단 검사 인프라 확충, 표준화된 검진 가이드라인 마련, 공중보건 검진 정책의 확대 등이 주요 요인으로 꼽힙니다.

유방암 검진 검사 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 36억 8,000만 달러에 달하며, CAGR은 8.1%에 달할 전망입니다. 예측 기간 중의 성장은 개인 맞춤형 암 검진 프로토콜 채택 증가, AI 기반 진단 툴 사용 확대, 유전자 검사 도입 확대, 조기 암 발견에 대한 관심 증가, 예방 종양학 서비스에 대한 투자 증가에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 첨단 영상 진단 기반 선별검사 도입 증가, 유전자 및 분자진단의 활용 확대, 영상 분석에 있으며, AI 통합의 발전, 멀티모달 스크리닝 기법의 확대, 조기 및 예방 진단에 대한 관심 강화 등을 꼽을 수 있습니다.

유방암 발생률 증가는 유방암 검진 검사 시장의 성장을 촉진할 것으로 예측됩니다. 유방암은 유방 조직에서 세포의 비정상적이고 통제할 수 없는 증식을 동반하며, 종양으로 발전하고 다른 부위로 전이될 수 있습니다. 유방암 환자 증가는 전 세계 인구의 고령화 추세에 기인합니다. 고령화는 발병 위험을 크게 증가시키고, 평균 수명의 연장으로 인해 더 많은 개인이 위험에 노출되기 때문입니다. 유방암 검진은 질병을 조기에 발견하기 위해 필수적이며, 이를 통해 치료 성과 향상과 사망률 감소를 기대할 수 있습니다. 예를 들어 2025년 3월 미국 비영리단체 Breastcancer.org는 2025년 약 31만 6,950명의 여성이 침윤성 유방암 진단을 받고, 비침윤성 유관암(DCIS) 5만 9,080건의 신규 사례가 발생할 것으로 예측했습니다. 또한 2024년 12월 캐나다 공중보건국은 2022년 캐나다에서 약 2만 8,600명의 여성이 유방암 진단을 받고 5,500명이 사망할 것으로 예상한다고 발표했습니다. 이러한 배경에서 유방암의 유병률 증가는 유방암 검진 시장 확대의 한 요인으로 작용하고 있습니다.

유방암 검진 검사 분야의 주요 기업은 접근성 향상, 조기 발견 촉진, 의료 서비스가 부족한 지역 및 오지 지역으로의 서비스 확대를 위해 이동식 검진 장치와 같은 첨단 솔루션 개발을 우선순위로 삼고 있습니다. 이 이동식 유닛은 유방촬영술과 같은 영상 진단 기술을 갖춘 이동식 시설로, 의료 접근성이 떨어지는 지역에서 유방암 검진을 제공하기 위해 고안된 것입니다. 예를 들어 2024년 9월 인도에 본사를 둔 제약회사 Granules India Ltd.는 소외된 지역사회의 유방암 검진을 촉진하기 위해 'Breast Health Express'를 도입했습니다. 이 장비는 첨단 유방촬영 및 초음파 시스템을 갖추고 있으며, 이동 중에도 양질의 검진을 가능하게 합니다. 이 사업은 농촌 지역이나 의료 서비스가 부족한 지역에 조기 발견 서비스를 제공하고, 이들 지역의 여성들이 중요한 의료 서비스를 받을 수 있도록 지원하는 것을 목표로 하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A breast cancer screening test is a medical procedure or diagnostic method designed to detect breast cancer at an early stage, often before any symptoms develop. The main objective of screening is to discover cancer when it is most treatable, thereby potentially lowering mortality rates and enhancing patient outcomes. Early diagnosis through breast cancer screening enables timely treatment and leads to a more favorable prognosis.

The primary types of diagnostic tests used in breast cancer screening include blood marker tests, imaging tests, genetic tests, and immunohistochemistry tests. Blood marker tests identify and quantify specific substances in the blood to support disease detection, monitoring, or risk evaluation. Different levels of risk-high-risk, moderate-risk, and average-risk populations-are considered, and the tests are utilized by various end users, including hospitals, diagnostic centers, cancer institutes, and research laboratories.

Tariffs are influencing the breast cancer screening test market by increasing costs of imported imaging equipment, diagnostic reagents, genetic testing kits, and advanced laboratory instruments. Diagnostic centers and hospitals in North America and Europe are most affected due to dependence on imported imaging systems and consumables, while Asia-Pacific faces higher costs for test kit manufacturing and exports. These tariffs are increasing screening service costs and slowing equipment upgrades. However, they are also supporting local manufacturing of diagnostic kits, regional laboratory expansion, and domestic development of screening technologies.

The breast cancer screening test market research report is one of a series of new reports from The Business Research Company that provides breast cancer screening test market statistics, including breast cancer screening test industry global market size, regional shares, competitors with a breast cancer screening test market share, detailed breast cancer screening test market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer screening test industry. This breast cancer screening test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast cancer screening test market size has grown strongly in recent years. It will grow from $2.49 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing breast cancer incidence awareness, widespread deployment of mammography screening programs, expansion of diagnostic laboratory infrastructure, availability of standardized screening guidelines, growing public health screening initiatives.

The breast cancer screening test market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising adoption of personalized cancer screening protocols, increasing use of ai-powered diagnostic tools, expansion of genetic testing adoption, growing focus on early-stage cancer detection, increasing investments in preventive oncology services. Major trends in the forecast period include increasing adoption of advanced imaging-based screening tests, rising use of genetic and molecular diagnostics, growing integration of ai in image interpretation, expansion of multi-modal screening approaches, enhanced focus on early and preventive diagnostics.

The increasing incidence of breast cancer is anticipated to drive the growth of the breast cancer screening test market. Breast cancer involves the abnormal and uncontrolled growth of cells in breast tissue, which can develop into a tumor and potentially spread to other body parts. The rise in breast cancer cases is attributed to the aging global population, as older age significantly raises the risk of developing the disease, and longer life expectancies mean a greater number of individuals are at risk. Screening tests for breast cancer are essential for identifying the disease in its early stages, thereby improving treatment outcomes and lowering mortality rates. For example, in March 2025, Breastcancer.org, a nonprofit organization based in the US, projected that approximately 316,950 women would be diagnosed with invasive breast cancer in 2025, along with 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Additionally, in December 2024, the Public Health Agency of Canada reported that an estimated 28,600 women in Canada were expected to be diagnosed with breast cancer in 2022, with 5,500 fatalities anticipated. As a result, the rising prevalence of breast cancer is contributing to the expansion of the breast cancer screening test market.

Leading companies in the breast cancer screening test sector are prioritizing the development of cutting-edge solutions such as mobile screening units to improve accessibility, increase early detection, and extend services to underserved or remote regions. These mobile units are transportable facilities equipped with diagnostic imaging technologies like mammography, designed to deliver on-site breast cancer screening in areas lacking adequate healthcare access. For instance, in September 2024, Granules India Ltd., a pharmaceutical company based in India, introduced the Breast Health Express to promote breast cancer screening in disadvantaged communities. Outfitted with advanced mammography and ultrasound systems, the unit facilitates quality screenings while on the move. This initiative aims to bring early detection services to rural and underserved areas, helping to ensure access to critical healthcare for women in these regions.

In August 2024, Hitachi High-Tech Corporation, a Japan-based producer of electronic and electrical equipment, entered into a strategic alliance with Gencurix Inc. for an undisclosed amount. Through this collaboration, Hitachi seeks to utilize its knowledge in in vitro diagnostics and digital technologies to create accurate and efficient molecular diagnostics for cancer. Gencurix Inc., headquartered in South Korea, specializes in breast cancer testing solutions.

Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton Dickinson and Company), Agilent Technologies Inc.

North America was the largest region in the breast cancer screening test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the breast cancer screening test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The breast cancer screening test market consists of revenues earned by entities by providing services such as early detection, risk assessment, and tumor detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer screening test market also consists of sales of products including ultrasound equipment, screening software, and breast self-examination kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Breast Cancer Screening Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses breast cancer screening test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for breast cancer screening test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast cancer screening test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Diagnostic Test Type: Blood Marker Test; Imaging Test; Genetic Test; Immunohistochemistry Test
• 2) By Risk Level: High-risk Population; Moderate-risk Population; Average-risk Population
• 3) By End User: Hospitals; Diagnostic Centres; Cancer Institutes; Research Laboratories
• Subsegments:
• 1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test; Gene Expression Profiling Test; Circulating Tumor Dna (Ctdna) Test; Proteomic Biomarker Test
• 2) By Imaging Test: Mammography; Magnetic Resonance Imaging Screening Test; Molecular Breast Imaging Test; Positron Emission Mammography; Ultrasound
• 3) By Genetic Test: Fluorescence In Situ Hybridization; Her Gene Test
• 4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test; Ki-67 Proliferation Marker Test; Progesterone Receptor (Pr) Test; Her2 Or Neu Test
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; Fujifilm Corporation; Koninklijke Philips NV; GE HealthCare Technologies Inc.; Quest Diagnostics Incorporated; Hologic Inc.; Hitachi High-Tech Corporation; Exact Sciences Corporation; Natera Inc.; Myriad Genetics Inc.; Canon Medical Systems Corporation; Provista Diagnostics Inc.; Niramai Health Analytix Pvt. Ltd.; Kheiron Medical Technologies Limited; UE LifeSciences Inc.; BD (Becton Dickinson and Company); Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Breast Cancer Screening Test Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Breast Cancer Screening Test Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Breast Cancer Screening Test Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Breast Cancer Screening Test Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Advanced Imaging-Based Screening Tests
  • 4.2.2 Rising Use Of Genetic And Molecular Diagnostics
  • 4.2.3 Growing Integration Of Ai In Image Interpretation
  • 4.2.4 Expansion Of Multi-Modal Screening Approaches
  • 4.2.5 Enhanced Focus On Early And Preventive Diagnostics

5. Breast Cancer Screening Test Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centres
• 5.3 Cancer Institutes
• 5.4 Research Laboratories
• 5.5 Specialty Oncology Clinics

6. Breast Cancer Screening Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Cancer Screening Test Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Breast Cancer Screening Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Breast Cancer Screening Test Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Breast Cancer Screening Test Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Breast Cancer Screening Test Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Cancer Screening Test Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Cancer Screening Test Market Segmentation

• 9.1. Global Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
• 9.2. Global Breast Cancer Screening Test Market, Segmentation By Risk Level, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• High-risk Population, Moderate-risk Population, Average-risk Population
• 9.3. Global Breast Cancer Screening Test Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories
• 9.4. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Blood Marker Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
• 9.5. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Mammography, Ultrasound
• 9.6. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fluorescence In Situ Hybridization, Her Gene Test
• 9.7. Global Breast Cancer Screening Test Market, Sub-Segmentation Of Immunohistochemistry Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

10. Breast Cancer Screening Test Market Regional And Country Analysis

• 10.1. Global Breast Cancer Screening Test Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Breast Cancer Screening Test Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Cancer Screening Test Market

• 11.1. Asia-Pacific Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Cancer Screening Test Market

• 12.1. China Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Cancer Screening Test Market

• 13.1. India Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Cancer Screening Test Market

• 14.1. Japan Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Cancer Screening Test Market

• 15.1. Australia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Cancer Screening Test Market

• 16.1. Indonesia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Cancer Screening Test Market

• 17.1. South Korea Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Cancer Screening Test Market

• 18.1. Taiwan Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Cancer Screening Test Market

• 19.1. South East Asia Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Cancer Screening Test Market

• 20.1. Western Europe Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Cancer Screening Test Market

• 21.1. UK Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Cancer Screening Test Market

• 22.1. Germany Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Cancer Screening Test Market

• 23.1. France Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Cancer Screening Test Market

• 24.1. Italy Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Cancer Screening Test Market

• 25.1. Spain Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Cancer Screening Test Market

• 26.1. Eastern Europe Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Cancer Screening Test Market

• 27.1. Russia Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Cancer Screening Test Market

• 28.1. North America Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Cancer Screening Test Market

• 29.1. USA Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Cancer Screening Test Market

• 30.1. Canada Breast Cancer Screening Test Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Cancer Screening Test Market

• 31.1. South America Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Cancer Screening Test Market

• 32.1. Brazil Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Cancer Screening Test Market

• 33.1. Middle East Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Cancer Screening Test Market

• 34.1. Africa Breast Cancer Screening Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Breast Cancer Screening Test Market, Segmentation By Diagnostic Test Type, Segmentation By Risk Level, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Cancer Screening Test Market Regulatory and Investment Landscape

36. Breast Cancer Screening Test Market Competitive Landscape And Company Profiles

• 36.1. Breast Cancer Screening Test Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Breast Cancer Screening Test Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Breast Cancer Screening Test Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Breast Cancer Screening Test Market Other Major And Innovative Companies

• Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton, Dickinson and Company), Agilent Technologies Inc.

38. Global Breast Cancer Screening Test Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Cancer Screening Test Market

40. Breast Cancer Screening Test Market High Potential Countries, Segments and Strategies

• 40.1 Breast Cancer Screening Test Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Breast Cancer Screening Test Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Breast Cancer Screening Test Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer